A prospective, multicenter, noninterventional study of decision factors in the first-line treatment of metastatic non-small cell lung cancer

被引：1

作者：

Sibille, Anne ^{[1
]}

Bustin, Frederique ^{[2
]}

Carestia, Luciano ^{[3
]}

Catala, Gaetan ^{[4
]}

Compere, Christophe ^{[5
]}

Cuppens, Kristof ^{[6
]}

Colinet, Benoit ^{[7
]}

Coulon, Stephanie ^{[8
]}

De Brucker, Nele ^{[9
]}

Decoster, Lore ^{[10
]}

Decoster, Lynn ^{[11
]}

Demedts, Ingel ^{[12
]}

Derijcke, Sofie ^{[13
]}

Deschepper, Koen ^{[14
]}

Galdermans, Danny ^{[15
]}

Janssens, Annelies ^{[16
]}

Ocak, Sebahat ^{[17
,18
]}

Oyen, Christel ^{[19
]}

Pat, Karin ^{[6
]}

Pieters, Thierry ^{[20
]}

Pruniau, Vincent ^{[8
]}

Surmont, Veerle ^{[21
]}

Vandekeere, Saar ^{[8
]}

Vansteenkiste, Johan ^{[19
,22
]}

机构：

[1] Univ Hosp Liege, Dept Pulmonol, Liege, Belgium

[2] CHR Citadelle, Dept Pulmonol, Liege, Belgium

[3] Clin Saint Pierre Ottignies, Dept Pulmonol, Ottignies, Belgium

[4] CH Jolimont, Dept Oncol, Haine St Paul, La Louviere, Belgium

[5] CHIREC Hosp, CHIREC Canc Inst, Dept Pulmonol, Brussels, Belgium

[6] Jessa Hosp, Dept Pulmonol & Thorac Oncol, Hasselt, Belgium

[7] Grand Hop Charleroi, Dept Pulmonol, Gilly, Belgium

[8] MSD Belgium, Med Affairs Dept, Brussels, Belgium

[9] Imelda Hosp, Dept Pneumonol, Bonheiden, Belgium

[10] Vrije Univ Brussel VUB, Univ Ziekenhuis Brussel UZ Brussel, Dept Med Oncol, Oncologisch Cent, Brussels, Belgium

[11] AZ Turnhout, Dept Pulmonol, Turnhout, Belgium

[12] AZ Delta, Dept Pulm Dis, Roeselare, Belgium

[13] AZ Groeninge, Dept Pulmonol, Kortrijk, Belgium

[14] Algemeen Ziekenhuis Nikolaas, St Niklaas, Belgium

[15] ZNA Middelheim, Dept Pulmonol, Antwerp, Belgium

[16] Antwerp Univ Hosp, MOCA Thorac Oncol, Edegem, Belgium

[17] CHU UCL Namur, Div Pulmonol, Godinne Site, Yvoir, Belgium

[18] Univ Catholique Louvain UCLouvain, Inst Rech Expt & Clin IREC, Pole Pneumol ENT & Dermatol PNEU, Brussels, Belgium

[19] Univ Hosp KU Leuven, Resp Oncol Unit, Leuven, Belgium

[20] Clin Univ St Luc, Dept Pulmonol, Saint Luc, Belgium

[21] Univ Ghent, Dept Resp Med, Ghent, Belgium

[22] Univ Hosp KU Leuven, Resp Oncol Unit, CONTACT Johan Vansteenkiste, Herestr 49, B-3000 Leuven, Belgium

来源：

ACTA ONCOLOGICA | 2022年 / 61卷 / 06期

关键词：

D O I：

10.1080/0284186X.2022.2063700

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：773 / 776

页数：4

共 50 条

[21] Combined paclitaxel and gemcitabine as first-line treatment in metastatic non-small cell lung cancer:: a multicentre phase II study
Douillard, JY
Lerouge, D
Monnier, A
Bennouna, J
Haller, AM
Sun, XS
Assouline, D
Grau, B
Rivière, A
BRITISH JOURNAL OF CANCER, 2001, 84 (09) : 1179 - 1184
[22] Combined paclitaxel and gemcitabine as first-line treatment in metastatic non-small cell lung cancer: a multicentre phase II study
J Y Douillard
D Lerouge
A Monnier
J Bennouna
A M Haller
X S Sun
D Assouline
B Grau
A Rivière
British Journal of Cancer, 2001, 84 : 1179 - 1184
[23] Chemotherapy beyond first-line in stage IV metastatic non-small cell lung cancer
Younes, Riad Naim
Pereira, Jost Rodrigues
Fares, Abdo Latif
Gross, Jefferson Luiz
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2011, 57 (06): : 686 - 691
[24] Prediction of Response to First Line Treatment for Metastatic Non-Small Cell Lung Cancer
Badawy, Ahmed
Khedr, Gehan
Arafat, Waleed
Bae, Sejong
Omar, Abbas
Grant, Stefan
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S908 - S908
[25] First-Line Treatment of Driver-Negative Non-Small Cell Lung Cancer
Kim, So Yeon
Gettinger, Scott
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 37 (03) : 557 - 573
[26] What Is the Standard First-Line Treatment for Advanced Non-Small Cell Lung Cancer?
Ricciuti, Biagio
Awad, Mark M.
CANCER JOURNAL, 2020, 26 (06): : 485 - 495
[27] Hyponatremia and hypoalbuminemia as predictive factors for response to first line treatment for metastatic non-small cell lung cancer
Badawy, A. A.
Khedr, G.
Omar, A.
Bae, S.
Arafat, W.
Grant, S.
ANNALS OF ONCOLOGY, 2016, 27
[28] First-Line Systemic Therapy for Non-Small Cell Lung Cancer
Heist, Rebecca S.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 31 (01) : 59 - +
[29] Non-small cell Lung Cancer Personalization of First-Line Therapy
Schmale, Ine
ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 (05)
[30] Exploration on the first-line treatment of ERBB2-altered advanced non-small cell lung cancer: A multicenter retrospective study
Chen, Jiayan
Xu, Chunwei
Wang, Qian
Lv, Jiawen
Lu, Wanjun
Zhang, Yixue
Yao, Yanwen
Gu, Xiaoling
Wu, Guannan
Hao, Yue
Pan, Weiwei
Wang, Wenxian
Zhang, Shirong
Lv, Tangfeng
Song, Yong
Wang, Dong
LUNG CANCER, 2023, 183

← 1 2 3 4 5 →